TCD601: Clinical Trials

1 trial of TCD601, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Terminated 1

Follow TCD601: new trials by email Literature Review of TCD601 trials Research Report on TCD601

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of TCD601 (Siplizumab) in Newly Diagnosed Adult Amyotrophic Lateral Sclerosis (ALS) Patients
TCD601 - ALS
Phase 1TerminatedITB-Med LLC72024-04-162026-07-17

Conditions studied

Amyotrophic Lateral Sclerosis (1)

Sponsors

ITB-Med LLC (1)

Countries

Sweden (1)

Top investigators

Fredrik Julin (1)